high-quantity and quality tag/ditag cDNAs for SAGE analysis.
Improved Host Range Selection for Recombinant Modified Vaccinia Virus Ankara
BioTechniques 34:694-700 (April 2003) Modified vaccinia virus Ankara (MVA) is a valuable tool for the expression of recombinant genes and can be used for such different purposes as the in vitro study of protein functions or the in vivo induction of antigen-specific cellular or humoral immune responses. A major advantage of MVA is that it allows for high-level gene expression despite being replication defective in human cells and most mammalian cells. MVA as a vaccine has an excellent track record for safety, can be handled under biosafety level 1 conditions, and has proven to be immunogenic and protective when delivering heterologous antigens in animals (1-8), and first human candidate vaccines have proceeded into clinical trials (9-11). We previously developed an efficient method for the selection of recombinant MVA by transient host range gene expression (12) , using the vaccinia virus K1L gene function as a stringent marker to rescue MVA growth on rabbit kidney RK-13 cells.
When using this straightforward selection protocol for the construction of multiple recombinant MVA carrying heterologous gene sequences including the gfp gene from the jellyfish Aequorea victoria, we observed that part of the isolated recombinant MVA was able to grow on RK13 cells but did not express the target gene of interest. Upon molecular analysis of multiple isolated MVA, we detected two different failures: (i) at the insertion site for the recombinant gene presence of only the K1L marker gene, no recombinant gene inserted and (ii) the region of natural deletion II within the MVA genome is affected/truncated ( Figure  1A ). The first observation is due to an initial single crossover event between the flank I gene sequences in the MVA genome and flank I repeat sequences of the transfer plasmid, followed by a second event of homologous recombination between the remaining flank I sequences, which results in the stable insertion of only the K1L marker sequence into the MVA genome. The second observation occurs when homologous recombination events take place between the K1L gene sequences in MVA and the transfer plasmid. The possibility of the latter recombination event has also been suggested by Tscharke and Smith (13) .
To test the respective importance of these undesired recombination events and to possibly improve the transient K1L selection technique, we adopted two measures: construction of MVA without K1L [MVA (II new ), Figure 1B ] and the design of a new transfer plasmid (pIII∆HR, Figure 1C ). To delete the remaining 261-bp K1L sequence from the MVA genome, we constructed the deletion plasmid pII new LZ-gpt-del: flank 1 of pUCII-LZ (14), a plasmid previously used for homologous recombination into the site of deletion II within the MVA genome, was substituted by a new flank (K2L) that did not contain the K1L gene sequences and had been isolated by PCR from MVA genomic DNA using primers IIf1newA, 5′-CAGCTGCAGCGGCC-GCCTTACACCGTACCC-3′, and IIf1-newB, 5′-CAGGCATGCGTAGAAC-GTAGATCCGG-3′. Additionally, a 315-bp repeat of the 5′ region of the N2L ORF (also isolated by PCR, using primers delIIA, 5′-CAGCTGCAGCCA-TAATGGTCAATCGCC-3′, and delIIB, 5′-CAGGCGGCCGCGGTATTCGAT-GATTATTTTTAACAAAATAAC-3′) was inserted downstream of the LacZgpt-cassette, yielding pII new LZ-gpt-del and allowing for the deletion of the marker cassette upon homologous recombination of N2L gene sequences. MVA (II new ) was generated by the transfection of pII new LZ-gpt-del DNA into primary chicken embryo fibroblasts (CEF) infected with MVA (clonal isolate F6), followed by the selection of β-galactosidase-producing viruses in the presence of mycophenolic acid, as previously described (7). After selection of recombinant MVA, selective pressure was removed, and marker-free viruses were isolated ( Figure 1B) . Additionally, to eliminate the possibility of homologous recombination between MVA genomic sequences and MVA repeat sequences in MVA transfer plasmids, we designed a new plasmid pIII∆HR that contains the K1L marker cassette now flanked by two short 216-bp repetitive sequences derived from the lacZ gene. This K1L marker cassette with the direct repeats on either side was excised from p∆K1L, which has been described previously (12) , and was inserted into pIIIdHR, replacing the K1L marker and flank I repeat to generate pIII∆HR (Figure 1C) . The genome of final MVA recombinant viruses will now contain the target gene sequences and one LacZ gene fragment. The insertion of additional foreign DNA might appear to result in less "clean" vector viruses, yet this inert sequence may serve as a general genetic marker for the convenient identification of recombinant MVA.
Finally, we examined the impact of these alterations on recombination efficiencies in infection/transfection experiments. CEF cells were infected with MVA (F6) or MVA (II new ) and transfected with pIIIdHR-gfp or pIII∆HR-gfp. Samples were harvested after 48 h, and aliquots were used to infect RK13 monolayers. After three days, infected monolayers were harvested completely, and the material was subjected to a second passage on RK13 cells. Three days after infection, the numbers of visible/ gfp fluorescent cell aggregates were determined by light/UV light microscopy. We then used this data to calculate the percentage of correct recombination events [i.e., insertion of the K1L marker cassette and the gfp gene into MVA (Table 1) ]. Using our conventional selection system [MVA (F6) and pIIIdHRgfp], we found 30.5% of all foci recombinant for K1L and gfp after the second RK13 passage. The deletion of the remaining K1L sequence from the MVA genome slightly improved correct recombination events [45%; MVA (II new ) and pIIIdHR-gfp], whereas the removal of the flank 1 repeat sequence from the MVA transfer plasmid resulted in a clear increase of desired recombination events (71%), even when using MVA still harboring leftover K1L sequences. We obtained virtually 100% efficiency when using new MVA and gfp-transfer plasmid [MVA (II new ) and pIII∆HR-gfp]. We performed one first "blind" passage on RK13 cells before plating dilutions and determining the number of foci because we had observed that, when counting GFP-positive cell aggregations in the first RK13 passage, the outcome suggested higher numbers of correct recombination events. However, about half of these virus isolates, when brought into the next passage, was unable to induce GFP-positive virus foci. This observation is probably based on unstable single recombination events and/or transient gfp expression from carryover plasmid DNA.
Taken together, we were able to further substantially improve our K1L-based selection technique by (i) the removal of the remaining K1L sequences within the MVA genome and (ii) the design of new MVA transfer plasmids carrying homologous non-MVA sequences for deletion of the transient marker gene. Each measure by itself already improved the generation of the desired recombinant viruses, albeit to different extents. Combined use of a MVA backbone virus, free of K1L sequences, with modified MVA vector plasmids resulted in very efficient selection and precise gene transfer into the targeted genome site and allows for the isolation of practically only MVA recombinant viruses. In an attempt to optimize parameters of genomic DNA (gDNA) hybridization to bacterial DNA arrays, we found that the method of gDNA labeling, especially gDNA denaturation, is the most crucial step for the quality of the process. The classical method for generating the random primer hybridization probe suggests one boils DNA in water or weakly buffered solution for 2-5 min (1). In addition, fragmentation of the gDNA, for example by sonication to an average length of 500-1500 bp, is also thought to be necessary for the method. Working with whole genome arrays of Bacillus subtilis, we found that boiling should be avoided. As an alternative, we suggest that an alkaline denaturation step before the random primer reaction is preferable and sufficient without recourse to sonication.
We illustrate these points by presenting the results of array hybridizations and by analyzing the labeled gDNA directly. Our B. subtilis arrays were prepared on nylon membranes similar to ones described previously (2,3) and contained PCR fragments of 4100 ORFs from B. subtilis obtained from Eurogentec (Seraing, Belgium). gDNA was isolated from 1.5 mL of a logarithmic culture (4) using Genomictip 20 (Qiagen, Hilden, Germany), following the manufacturer's instructions, and recovered in TE buffer. After purification, DNA was either freshly used or stored for no longer than two days at 4°C. All DNA samples obtained by this method typically had an A 260 /A 280 ratio about 1.8. The purified DNA appears as a single band near the wells after 0.6% agarose gel electrophoresis, with an estimated size of approximately 50 kb. All buffers were prepared with nanopure (divalent cation-free) nuclease-free water.
Purified gDNA was either directly labeled using the Prime-It ® II kit (Stratagene, La Jolla, CA, USA) or denatured using the procedure described here. gDNA (200 ng) was incubated with 200 mM NaOH in a total volume of 50 µL for 20 min at room temperature or for 10 min at 70°C. The mixture was then precipitated by adding 20 µL 5 M ammonium acetate (pH 7.5) and 175 µL ethanol for 2 h at -20°C. After centrifugation at 13 000× g at 4°C for 20 min and washing with 70% ethanol, the pel- Figure 1 . Hybridization of radioactive labeled gDNA to nylon DNA arrays. B. subtilis gDNA samples were differently denatured before random primed labeling. The same part of the arrays is shown. (A) NaOH treatment at room temperature for 20 min and (B) at 70°C for 10 min before labeling. We also used the protocol described by the manufacturer of Prime-It II (Stratagene) with slight modifications: denaturation of DNA was performed either by incubation for 5 min (C), as recommended, or (D) for 10 min in a boiling water bath. Labeling and hybridization of all samples were performed as described in the text.
